Email Print this page Bookmark this page

About LACRISERT®

LACRISERT® is a small, translucent ophthalmic insert that dissolves slowly, releasing a protective layer of cellulosic polymer over the cornea and conjunctiva to stabilize and thicken the tear film. LACRISERT® retains fluid allowing your patients to retain their tears for continuous Dry Eye relief throughout the day. 1-3

LACRISERT® has no preservatives or other additives and offers the convenience of just one application daily.*3,4 Progressive visual deterioration which occurs in some patients may be retarded, halted, or sometimes reversed.3

LACRISERT® is indicated for your patient if3:

  • You have diagnosed the patient with moderate to severe Dry Eye
  • Your patient has used artificial tears repeatedly for temporary relief and is in need of an all-day, long-term treatment alternative for relief
  • Your patient remains symptomatic even after using artificial tears ≥4 times a day

LACRISERT® is also indicated for use in patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions. 3

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. 3

This video will explain more about LACRISERT® and for whom it is indicated.

 

Click the following links for more information about LACRISERT®:

Click here to contact Customer Service via e-mail.

See Full Prescribing Information

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

*For most Dry Eye sufferers, one LACRISERT® inserted in each eye in the morning lasts the entire day. But some people may need to use it twice a day for symptom relief. 3

References: 1. Breslin CW, Katz J, Haufman HE, Katz I. Slow release artificial tears. In: Leopold IH, Burns RP, eds. Symposium on Ocular Therapy. New York, NY: John Wiley & Sons; 1977;10:77-83.
2. Katz JI, Kaufman HE, Breslin C, Katz IM. Slow-release artificial tears and the treatment of keratitis sicca. Ophthalmology. 1978;85(8):787-793. 3. Lacrisert [prescribing information]. Lawrenceville, NJ: Aton Pharma, Inc; 2007.

 

sample request using Lacrisert video patient tip sheet
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807